ProfileGDS5822 / ILMN_1234852
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 32% 16% 0% 12% 18% 31% 32% 10% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 115.932
GSM1276600PDAC Late Ablation Control 213.616
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 11.40
GSM1276603PDAC Late Ablation 29.212
GSM1276604PDAC Late Ablation 311.418
GSM1303940PDAC Late Ablation_anti-CTLA4 115.831
GSM1303941PDAC Late Ablation_anti-CTLA4 215.632
GSM1303942PDAC Late Ablation_anti-CTLA4 36.410